Legis Daily

Strengthening Pharmacy Access for Seniors Act

USA118th CongressS-2405| Senate 
| Updated: 7/20/2023
John Thune

John Thune

Republican Senator

South Dakota

Cosponsors (4)
Debbie Stabenow (Democratic)John Barrasso (Republican)Sherrod Brown (Democratic)Gary C. Peters (Democratic)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Strengthening Pharmacy Access for Seniors Act This bill prohibits prescription drug plan (PDP) sponsors and pharmacy benefit managers from restricting access to any covered drug under the Medicare prescription drug benefit to a subset of their network pharmacies except for limited access drugs. Limited access drugs are those for which the Food and Drug Administration has restricted distribution to certain facilities or physicians or for which dispensing requires extraordinary special handling, coordination, or education that a network pharmacy cannot meet. PDP sponsors must annually report to the Centers for Medicare & Medicaid Services (1) a list of drugs that the PDP sponsor designated as limited access drugs, (2) the reasons for the designations, (3) information about relevant requirements for pharmacies with respect to these drugs, and (4) the types of pharmacies dispensing these drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 20, 2023
Introduced in Senate
Jul 20, 2023
Read twice and referred to the Committee on Finance. (text: CR S3461-3462)
  • July 20, 2023
    Introduced in Senate


  • July 20, 2023
    Read twice and referred to the Committee on Finance. (text: CR S3461-3462)

Health

Strengthening Pharmacy Access for Seniors Act

USA118th CongressS-2405| Senate 
| Updated: 7/20/2023
Strengthening Pharmacy Access for Seniors Act This bill prohibits prescription drug plan (PDP) sponsors and pharmacy benefit managers from restricting access to any covered drug under the Medicare prescription drug benefit to a subset of their network pharmacies except for limited access drugs. Limited access drugs are those for which the Food and Drug Administration has restricted distribution to certain facilities or physicians or for which dispensing requires extraordinary special handling, coordination, or education that a network pharmacy cannot meet. PDP sponsors must annually report to the Centers for Medicare & Medicaid Services (1) a list of drugs that the PDP sponsor designated as limited access drugs, (2) the reasons for the designations, (3) information about relevant requirements for pharmacies with respect to these drugs, and (4) the types of pharmacies dispensing these drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 20, 2023
Introduced in Senate
Jul 20, 2023
Read twice and referred to the Committee on Finance. (text: CR S3461-3462)
  • July 20, 2023
    Introduced in Senate


  • July 20, 2023
    Read twice and referred to the Committee on Finance. (text: CR S3461-3462)
John Thune

John Thune

Republican Senator

South Dakota

Cosponsors (4)
Debbie Stabenow (Democratic)John Barrasso (Republican)Sherrod Brown (Democratic)Gary C. Peters (Democratic)

Finance Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted